192 related articles for article (PubMed ID: 32686901)
1. Progress and Perspectives in the Development of Lentiviral Vector Producer Cells.
Ferreira MV; Cabral ET; Coroadinha AS
Biotechnol J; 2021 Jan; 16(1):e2000017. PubMed ID: 32686901
[TBL] [Abstract][Full Text] [Related]
2. Lentiviral Vector Production in Suspension Culture Using Serum-Free Medium for the Transduction of CAR-T Cells.
Do Minh A; Tran MY; Kamen AA
Methods Mol Biol; 2020; 2086():77-83. PubMed ID: 31707669
[TBL] [Abstract][Full Text] [Related]
3. Development of Third-generation Cocal Envelope Producer Cell Lines for Robust Lentiviral Gene Transfer into Hematopoietic Stem Cells and T-cells.
Humbert O; Gisch DW; Wohlfahrt ME; Adams AB; Greenberg PD; Schmitt TM; Trobridge GD; Kiem HP
Mol Ther; 2016 Aug; 24(7):1237-46. PubMed ID: 27058824
[TBL] [Abstract][Full Text] [Related]
4. Genome editing for scalable production of alloantigen-free lentiviral vectors for
Milani M; Annoni A; Bartolaccini S; Biffi M; Russo F; Di Tomaso T; Raimondi A; Lengler J; Holmes MC; Scheiflinger F; Lombardo A; Cantore A; Naldini L
EMBO Mol Med; 2017 Nov; 9(11):1558-1573. PubMed ID: 28835507
[TBL] [Abstract][Full Text] [Related]
5. Scalable Lentiviral Vector Production Using Stable HEK293SF Producer Cell Lines.
Manceur AP; Kim H; Misic V; Andreev N; Dorion-Thibaudeau J; Lanthier S; Bernier A; Tremblay S; Gélinas AM; Broussau S; Gilbert R; Ansorge S
Hum Gene Ther Methods; 2017 Dec; 28(6):330-339. PubMed ID: 28826344
[TBL] [Abstract][Full Text] [Related]
6. Clinical use of lentiviral vectors.
Milone MC; O'Doherty U
Leukemia; 2018 Jul; 32(7):1529-1541. PubMed ID: 29654266
[TBL] [Abstract][Full Text] [Related]
7. LentiPro26: novel stable cell lines for constitutive lentiviral vector production.
Tomás HA; Rodrigues AF; Carrondo MJT; Coroadinha AS
Sci Rep; 2018 Mar; 8(1):5271. PubMed ID: 29588490
[TBL] [Abstract][Full Text] [Related]
8. Lentiviral Vector Bioprocessing.
Perry C; Rayat ACME
Viruses; 2021 Feb; 13(2):. PubMed ID: 33572347
[TBL] [Abstract][Full Text] [Related]
9. RD2-MolPack-Chim3, a packaging cell line for stable production of lentiviral vectors for anti-HIV gene therapy.
Stornaiuolo A; Piovani BM; Bossi S; Zucchelli E; Corna S; Salvatori F; Mavilio F; Bordignon C; Rizzardi GP; Bovolenta C
Hum Gene Ther Methods; 2013 Aug; 24(4):228-40. PubMed ID: 23767932
[TBL] [Abstract][Full Text] [Related]
10. Development of a perfusion process for continuous lentivirus production using stable suspension producer cell lines.
Klimpel M; Terrao M; Ching N; Climenti V; Noll T; Pirzas V; Laux H
Biotechnol Bioeng; 2023 Sep; 120(9):2622-2638. PubMed ID: 37148430
[TBL] [Abstract][Full Text] [Related]
11. Influence of mildly acidic pH conditions on the production of lentiviral and retroviral vectors.
Holic N; Seye AK; Majdoul S; Martin S; Merten OW; Galy A; Fenard D
Hum Gene Ther Clin Dev; 2014 Sep; 25(3):178-85. PubMed ID: 25073060
[TBL] [Abstract][Full Text] [Related]
12. Optimised protocols to generate high titre lentiviral vectors using a novel transfection agent enabling extended HEK293T culture following transient transfection and suspension culture.
Suleman S; Fawaz S; Roberts T; Ellison S; Bigger B; Themis M
J Virol Methods; 2024 Apr; 325():114884. PubMed ID: 38218417
[TBL] [Abstract][Full Text] [Related]
13. Concise review on optimized methods in production and transduction of lentiviral vectors in order to facilitate immunotherapy and gene therapy.
Gouvarchin Ghaleh HE; Bolandian M; Dorostkar R; Jafari A; Pour MF
Biomed Pharmacother; 2020 Aug; 128():110276. PubMed ID: 32502836
[TBL] [Abstract][Full Text] [Related]
14. Lentivirus production is influenced by SV40 large T-antigen and chromosomal integration of the vector in HEK293 cells.
Gama-Norton L; Botezatu L; Herrmann S; Schweizer M; Alves PM; Hauser H; Wirth D
Hum Gene Ther; 2011 Oct; 22(10):1269-79. PubMed ID: 21554103
[TBL] [Abstract][Full Text] [Related]
15. Large-scale production means for the manufacturing of lentiviral vectors.
Schweizer M; Merten OW
Curr Gene Ther; 2010 Dec; 10(6):474-86. PubMed ID: 21054245
[TBL] [Abstract][Full Text] [Related]
16. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
[TBL] [Abstract][Full Text] [Related]
17. Production of Retrovirus-Based Vectors in Mildly Acidic pH Conditions.
Holic N; Fenard D
Methods Mol Biol; 2016; 1448():41-8. PubMed ID: 27317171
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in lentiviral vectors for gene therapy.
Wang X; Ma C; Rodríguez Labrada R; Qin Z; Xu T; He Z; Wei Y
Sci China Life Sci; 2021 Nov; 64(11):1842-1857. PubMed ID: 34708326
[TBL] [Abstract][Full Text] [Related]
19. Improvement of De Novo Cholesterol Biosynthesis Efficiently Promotes the Production of Human Immunodeficiency Virus Type 1-Derived Lentiviral Vectors.
Holic N; Frin S; Seye AK; Galy A; Fenard D
Hum Gene Ther Methods; 2017 Apr; 28(2):67-77. PubMed ID: 28042946
[TBL] [Abstract][Full Text] [Related]
20. Phase I/II Manufacture of Lentiviral Vectors Under GMP in an Academic Setting.
Dasgupta A; Tinch S; Szczur K; Ernst R; Shryock N; Kaylor C; Lewis K; Day E; Truong T; Swaney W
Methods Mol Biol; 2020; 2086():27-60. PubMed ID: 31707666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]